Clinical Cancer Research Landon Prizes for Basic and Translational Cancer Research Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 7289-7295, December 15, 2007. doi: 10.1158/1078-0432.CCR-07-1758
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahtouk, K.
Right arrow Articles by Klein, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahtouk, K.
Right arrow Articles by Klein, B.
Related Collections
Right arrow Therapeutics and Targets
Right arrow Therapeutics and Targets: Identification, Validation, and Markers
Right arrow Epidemiology and Prevention: Genetics and Biomarkers

Review

Input of DNA Microarrays to Identify Novel Mechanisms in Multiple Myeloma Biology and Therapeutic Applications

Karène Mahtouk1,2, Dirk Hose5, John De Vos1,2,3, Jérôme Moreaux1,2, Michel Jourdan2, Jean François Rossi1,3,4, Thierry Rème1,2, Harmut Goldschmidt5 and Bernard Klein1,2,3

Authors' Affiliations: 1 CHU Montpellier, Institut de Recherche en Biothérapies, Hôpital Saint-Eloi; 2 Institut National de la Sante et de la Recherche Medicale, U847; 3 Université Montpellier1, UFR de Médecine; 4 CHU Montpellier, Service d'Hématologie et d'Oncologie Médicale, Montpellier, France; and 5 Medizinische Klinik und Poliklinik V, Universitätsklinikum Heidelberg, Germany

Requests for reprints: Bernard Klein, Institut de Recherche en Biothérapies, CHU Montpellier, Hôpital Saint-Eloi, Av Augustin Fliche, Montpellier F-34285, France. Phone: 33-4-67-33-78-88; Fax: 33-4-67-33-70-05; E-mail: klein{at}montp.inserm.fr.

Multiple myeloma is a B-cell neoplasia characterized by the proliferation of a clone of malignant plasma cells in the bone marrow. We review here the input of gene expression profiling of myeloma cells and of their tumor microenvironment to develop new tumor classifiers, to better understand the biology of myeloma cells, to identify some mechanisms of drug sensitivity and resistance, to identify new myeloma growth factors, and to depict the complex interactions between tumor cells and their microenvironment. We discuss how these findings may improve the clinical outcome of this still incurable disease.




This article has been cited by other articles:


Home page
CRO ContentHome page
G. C. Prendergast
Metastasis, miRNAs, Multiple Myeloma, and More
Cancer Reviews Online Content, January 1, 2008; 2008(1): 1 - 1.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.